-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Orthopoxvirus
- Others
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Virus Protease
- Antiviral intermediates
FWM-5
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/2757194-04-8.gif)
| Category | SARS-CoV |
| CAS | 2757194-04-8 |
| Description | FWM-5 is a potent NSP13 helicase inhibitor. SARS-COV-2 NSP13 helicase enzyme plays crucial role in the virus life cycle. |
Product Information
| Synonyms | FWM-5|ZINC17246384|HY-144798|CS-0434619 |
| Molecular Weight | 374.39 |
| Molecular Formula | C15H10N4O4S2 |
| Canonical SMILES | C1=CC=C2C(=C1)C(C3=C(O2)NC(=S)NC3=O)C4=C(NC(=S)NC4=O)O |
| Purity | ≥98% |
| Solubility | In vitro: 10 mM in DMSO |
| Appearance | Solid powder |
| Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -23 C for long term (months to years). |
| Complexity | 776 |
| Exact Mass | 374.01434716 |
| Target | SARS-CoV |
| XLogP3-AA | 0.4 |
